Pegfilgrastim
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Peripheral Blood Stem Cell Transplantation
Conditions
Peripheral Blood Stem Cell Transplantation
Trial Timeline
May 28, 2019 → Aug 28, 2020
NCT ID
NCT03993639About Pegfilgrastim
Pegfilgrastim is a phase 2 stage product being developed by Kyowa Kirin for Peripheral Blood Stem Cell Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT03993639. Target conditions include Peripheral Blood Stem Cell Transplantation.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03993639 | Phase 2 | Completed |
| NCT00364468 | Phase 2 | Completed |
Competing Products
20 competing products in Peripheral Blood Stem Cell Transplantation